Investing in WHOOP: Understanding Growth-Stage Secondary Markets
For years, the most valuable companies in the world stayed private longer, growing into billion-dollar businesses well before ordinary investors ever had the chance to participate. Whoop is one of those companies. Founded in 2012, it has quietly become one of the most data-rich and commercially formidable health technology platforms on the planet. And now, for the first time, eligible UK investors can gain access to equity in Whoop through a direct secondary share sale on Republic Europe.
Before diving into why this opportunity matters, it is worth taking a step back to understand what a growth-stage secondary actually is, and why it represents a different way to invest.
What Is a Secondary Share Sale?
When a company raises a funding round, it issues new shares to investors in exchange for capital. That is called a primary transaction. A secondary transaction is different. In a secondary sale, no new shares are created and no capital goes to the company. Instead, an existing shareholder, whether that is an early employee, a seed-stage investor, or a venture fund looking to return capital, sells their existing shares to a new buyer.
The mechanics matter because they change the nature of what you are buying. In a secondary, you are purchasing a stake from someone who has already held it, often for years. The company itself does not need to consent to a fundraise or open a new round. What you gain is economic exposure to a company that has already built a substantial business, at a later stage of its development but before it has opened up to the public markets.
For decades, this kind of transaction was exclusively available to institutional investors, hedge funds, and high-net-worth individuals with access to specialist secondary trading desks. Republic Europe is changing that.
How Republic Europe Structures This Offering
Through this campaign, Republic Europe is pooling capital from investors and using it, via the Republic Europe Nominee, to purchase shares directly from an existing Whoop shareholder. The structure bypasses the institutional gatekeepers that have traditionally made late-stage venture equity inaccessible to individual investors.
This is not a fund with layers of management fees or an indirect exposure vehicle. It is a direct secondary share sale. Investors who participate hold economic exposure to Whoop equity through a regulated nominee structure, authorised and regulated by the Financial Conduct Authority (FCA) under firm reference number 550317.
The campaign was approved as a financial promotion on 5 June 2026.
Why WHOOP, and Why Now?
WHOOP has over a decade of operating history, a clear product, and a large and growing user base.
The company makes a wearable health platform and subscription service designed to track sleep, recovery, and physical strain. Its 2.5 million active members generate billions of hours of continuous physiological data, which powers the insights at the core of the product (Source: WHOOP Series G Press Release, whoop.com). That scale of data is a significant competitive asset, and one that becomes more valuable over time.
The commercial trajectory is equally notable. In 2025, Whoop grew subscription bookings by 103% YOY, ending the year at a $1.1 billion annual revenue run rate. Critically, the business reached fully cash-flow positive status over the same period (Source: WHOOP Series G Press Release, whoop.com).
That combination of rapid revenue growth and positive cash flow is rare in consumer technology at this scale.
In March 2026, Whoop closed a $575 million Series G funding round led by Collaborative Fund, with participation from high-profile athlete investors including Cristiano Ronaldo, LeBron James, Rory McIlroy, Virgil van Dijk, and others (Source: WHOOP Series G Press Release, whoop.com). That round valued the company at $10.1 billion. CEO Will Ahmed has stated publicly that an IPO is the company’s next step.
The Case for Secondary Investing at This Stage
So, what’s the opportunity to invest via a growth-stage secondary at this point in WHOOP’s lifecycle?
Established Business/A Business beyond the early stage phase. WHOOP has already proven its product, grown a subscriber base of over 2.5 million members, and demonstrated a path to cash-flow profitability.
Access before public markets open. If WHOOP proceeds with an IPO, the public listing will likely be priced in a way that reflects its existing valuation and the institutional demand for its shares. Secondary investors who enter before the IPO have the opportunity to hold equity ahead of that event.
A transparent, regulated pathway. Historically, individual investors in Europe had no practical means of participating in late-stage private equity transactions of this kind. Republic Europe’s structure changes that, and does so within a regulated framework.
How to Get Priority Access
Republic Europe is currently accepting pre-registrations for the WHOOP secondary campaign. Investors who join the priority list will be notified by email as soon as the campaign opens, before it becomes available to the general public on the platform.
To register your interest, visit europe.republic.com/whp-secondary/coming-soon.
Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Republic Europe is authorised and regulated by the Financial Conduct Authority, firm reference number 550317. This is not investment advice. Please read all risk warnings before investing. This campaign was approved as a financial promotion on 5 June 2026.
